Ads
-
Related paper
- Case report of three distinctive pulmonary toxicities related to durvalumab (PD-L1 inhibitor) consolidation therapy in locally advanced non-small cell lung cancer
- Camrelizumab Combined with Radiotherapy Treating Locally Advanced Non-Small Cell Lung Cancer that has Failed Chemotherapy: A Case Report |Biomedgrid
- A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus
- Brigatinib treatment for primary lung lesions in non-small-cell lung cancer based on ALK gene rearrangement detected in resected brain metastases: A case report and literature review
- INVASIVE PULMONARY ASPERGILLOSIS FOLLOWING BEVACIZUMAB TREATMENT FOR NON-SMALL CELL LUNG CANCER
- THE CONTENT OF VEGF, COX-2 AND PGE-2 DEPENDING ON THE OBJECTIVE RESPONSE TO RADIATION THERAPY IN COMBINATION WITH A COX-2 INHIBITOR IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
- First-line Treatment in Elderly Patients with Advanced Non-small Cell Lung Cancer
- Study on Traditional Chinese Medicine Maintenance Therapy for Advanced Non-small Cell Lung Cancer
- STUDY OF MOLECULAR DOCKING AND MOLECULAR DYNAMIC OF FLAVONOL COMPOUNDS AS A B-CELL LYMPHOMA-2 (BCL-2) RECEPTOR INHIBITOR IN SMALL LUNG CANCER
- KAN0438757: A NOVEL PFKFB3 INHIBITOR THAT INDUCES PROGRAMMED CELL DEATH AND SUPPRESSES CELL MIGRATION IN NON-SMALL CELL LUNG CARCINOMA CELLS